<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PBIOLOGY-D-11-01871</article-id><article-id pub-id-type="doi">10.1371/journal.pbio.1001138</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Biochemistry</subject>
          </subj-group>
          <subj-group>
            <subject>Microbiology</subject>
          </subj-group>
          <subj-group>
            <subject>Molecular cell biology</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Chemistry</subject>
          <subj-group>
            <subject>Chemical biology</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Infectious diseases</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Chemistry</subject>
          <subject>Infectious Diseases</subject>
          <subject>Biochemistry</subject>
        </subj-group>
      </article-categories><title-group><article-title>Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage <italic>Plasmodium falciparum</italic></article-title><alt-title alt-title-type="running-head">Chemical Rescue of Apicoplast-Minus <italic>P. falciparum</italic></alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Yeh</surname>
            <given-names>Ellen</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>DeRisi</surname>
            <given-names>Joseph L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Pathology, Stanford Medical School, Stanford, California, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Striepen</surname>
            <given-names>Boris</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">University of Georgia, United States of America</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">ellenyeh@stanford.edu</email> (EY); <email xlink:type="simple">joe@derisilab.ucsf.edu</email> (JLD)</corresp>
        <fn fn-type="con">
          <p>The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: EY JD. Performed the experiments: EY. Analyzed the data: EY JD. Wrote the paper: EY JD.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <month>8</month>
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>30</day>
        <month>8</month>
        <year>2011</year>
      </pub-date><volume>9</volume><issue>8</issue><elocation-id>e1001138</elocation-id><history>
        <date date-type="received">
          <day>10</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>7</month>
          <year>2011</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><copyright-holder>Yeh, DeRisi</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="uri" id="related1" related-article-type="companion" xlink:href="info:doi/10.1371/journal.pbio.1001137" xlink:type="simple">
        <article-title>What Do Human Parasites Do with a Chloroplast Anyway?</article-title>
      </related-article><abstract abstract-type="toc">
        <p>The only essential function of a unique plastid organelle, the apicoplast, in blood-stage <italic>P. falciparum</italic> is the production of isoprenoid precursors.</p>
      </abstract><abstract>
        <p><italic>Plasmodium</italic> spp parasites harbor an unusual plastid organelle called the apicoplast. Due to its prokaryotic origin and essential function, the apicoplast is a key target for development of new anti-malarials. Over 500 proteins are predicted to localize to this organelle and several prokaryotic biochemical pathways have been annotated, yet the essential role of the apicoplast during human infection remains a mystery. Previous work showed that treatment with fosmidomycin, an inhibitor of non-mevalonate isoprenoid precursor biosynthesis in the apicoplast, inhibits the growth of blood-stage <italic>P. falciparum</italic>. Herein, we demonstrate that fosmidomycin inhibition can be chemically rescued by supplementation with isopentenyl pyrophosphate (IPP), the pathway product. Surprisingly, IPP supplementation also completely reverses death following treatment with antibiotics that cause loss of the apicoplast. We show that antibiotic-treated parasites rescued with IPP over multiple cycles specifically lose their apicoplast genome and fail to process or localize organelle proteins, rendering them functionally apicoplast-minus. Despite the loss of this essential organelle, these apicoplast-minus auxotrophs can be grown indefinitely in asexual blood stage culture but are entirely dependent on exogenous IPP for survival. These findings indicate that isoprenoid precursor biosynthesis is the only essential function of the apicoplast during blood-stage growth. Moreover, apicoplast-minus <italic>P. falciparum</italic> strains will be a powerful tool for further investigation of apicoplast biology as well as drug and vaccine development.</p>
      </abstract><abstract abstract-type="summary">
        <title>Author Summary</title>
        <p>Malaria caused by <italic>Plasmodium</italic> spp parasites is a profound human health problem that has shaped our evolutionary past and continues to influence modern day with a disease burden that disproportionately affects the world's poorest and youngest. New anti-malarials are desperately needed in the face of existing or emerging drug resistance to available therapies, while an effective vaccine remains elusive. A plastid organelle, the apicoplast, has been hailed as <italic>Plasmodium</italic>'s “Achilles' heel” because it contains bacteria-derived pathways that have no counterpart in the human host and therefore may be ideal drug targets. However, more than a decade after its discovery, the essential functions of the apicoplast remain a mystery, and without a specific pathway or function to target, development of drugs against the apicoplast has been stymied. In this study, we use a simple chemical method to generate parasites that have lost their apicoplast, normally a deadly event, but which survive—“rescued” by the addition of an essential metabolite to the culture. This chemical rescue demonstrates that the apicoplast serves only a single essential function, namely isoprenoid precursor biosynthesis during blood-stage growth, validating this metabolic function as a viable drug target. Moreover, the apicoplast-minus <italic>Plasmodium</italic> strains generated in this study will be a powerful tool for identifying apicoplast-targeted drugs and as a potential vaccine strain with significant advantages over current vaccine technologies.</p>
      </abstract><funding-group><funding-statement>This work was funded by the Howard Hughes Medical Institution (HHMI). EY was supported by Stanford Medical School and Stanford Hospital &amp; Clinics. JD was supported by HHMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="10"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>The discovery of a plastid organelle, the apicoplast, in <italic>Plasmodium</italic> spp. (responsible for 250 million cases of human malaria each year) and other Apicomplexa parasites instantly made it a key target in the development of new therapies against these pathogens <xref ref-type="bibr" rid="pbio.1001138-Wilson1">[1]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Khler1">[3]</xref>. The need for new anti-malarials is particularly urgent given the documentation of developing resistance to the current last-line therapy in the deadliest species, <italic>P. falciparum</italic> <xref ref-type="bibr" rid="pbio.1001138-Dondorp1">[4]</xref>. Several features of this organelle make it both biologically fascinating and an attractive therapeutic target. The apicoplast is derived from secondary endosymbiosis of a plastid-bearing red algae and is therefore prokaryotic in origin, containing pathways that have no counterpart in the human host <xref ref-type="bibr" rid="pbio.1001138-Khler1">[3]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Fast1">[5]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Janoukovec1">[6]</xref>. During the course of evolution, the apicoplast has lost its photosynthetic function and transferred most of its genome to the nucleus, requiring a dedicated protein targeting pathway to localize the majority of its over 500 gene products into the organelle <xref ref-type="bibr" rid="pbio.1001138-Waller1">[7]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. The remaining 35 kb apicoplast genome encodes ∼50 mostly housekeeping genes, including ribosome subunits, tRNAs, RNA polymerase, and a chaperone thought to be involved in protein import <xref ref-type="bibr" rid="pbio.1001138-Wilson1">[1]</xref>. Despite its minimalization, the apicoplast continues to serve essential though poorly defined metabolic function(s). In <italic>Plasmodium</italic>, apicoplast function is necessary for both intraerythrocytic and intrahepatic development in the human host <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Stanway1">[10]</xref>. Whether the apicoplast is required for sexual stage development in the mosquito is currently unknown <xref ref-type="bibr" rid="pbio.1001138-Sullivan1">[11]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Aminake1">[14]</xref>.</p>
      <p>The essential role of the apicoplast has been clearly demonstrated by the effect of antibiotics on blood-stage <italic>P. falciparum</italic>. Dahl et al. showed that antibiotics that inhibit prokaryotic transcription or translation, such as doxycycline, specifically blocks expression of the apicoplast genome <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Dahl2">[15]</xref>. Parasites treated during first 48 h life cycle show no obvious defect from the loss of apicoplast-encoded gene products: Organelle morphology, genome replication, protein targeting, and segregation during cell division remain intact. Likewise, parasites progress normally through the ring, trophozoite, and schizont developmental stages, giving rise to daughter merozoites that successfully reinvade to establish infection of a new host cell. Instead, a curious “delayed death” phenotype is observed, whereby the deleterious effects of antibiotic inhibition accumulate in the <italic>progeny</italic> of treated parasites. In this 2<sup>nd</sup> life cycle following antibiotic treatment, the apicoplast genome fails to replicate. Protein import function is lost. Finally, the organelle itself fails to replicate and segregate during cell division. Because the apicoplast cannot be generated de novo and must be inherited at each cell division, the failure of organelle replication and segregation in these parasites results in loss of the apicoplast in daughter cells and parasite death. Overall, antibiotic-induced delayed death begins with specific inhibition of apicoplast transcription and translation in one life cycle and ends with irreversible apicoplast loss and death in the subsequent cycle. A similar delayed death has been observed in <italic>Toxoplasma gondii</italic> following antibiotic treatment or transgene expression that cause apicoplast loss <xref ref-type="bibr" rid="pbio.1001138-Fichera1">[16]</xref>,<xref ref-type="bibr" rid="pbio.1001138-He1">[17]</xref>.</p>
      <p>Despite its promise as <italic>Plasmodium</italic>'s “Achilles heel,” the function of the apicoplast has eluded researchers in the nearly 20 years since its discovery. Without knowledge of specific proteins or pathways suitable as drug targets, particularly during the clinically symptomatic blood stage, efforts to develop apicoplast-directed therapies (beyond known antibiotics) have been stymied. An astounding 5%–10% of the nuclear genome is predicted to contain an apicoplast targeting signal, yet 70% of these apicoplast gene products are of unknown function <xref ref-type="bibr" rid="pbio.1001138-Zuegge1">[18]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Ralph1">[20]</xref>. Pathways that have been identified include those for the biosynthesis of isoprenoid precursors, fatty acids, heme, Fe-S clusters, and lipoic acid <xref ref-type="bibr" rid="pbio.1001138-Seeber1">[21]</xref>. While in silico analysis has been revealing, many pathways will go undetected and the essentiality of predicted pathways throughout the parasite's complex life cycle needs to be experimentally validated. For example, inhibition by the antibiotic triclosan initially suggested that apicoplast-located type II fatty acid biosynthesis was essential in blood-stage parasites, prompting the development of fatty acid inhibitors as anti-malarials <xref ref-type="bibr" rid="pbio.1001138-Surolia1">[22]</xref>. Later, genetic deletion of fatty acid biosynthetic genes definitively proved that this pathway is not required for blood stage growth and instead is critical for liver stage development <xref ref-type="bibr" rid="pbio.1001138-Yu1">[23]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Vaughan1">[24]</xref>. Unfortunately, discovery and validation of apicoplast pathways has been hampered by the limited ability to generate knockouts of essential genes, isolate the organelle, or purify Plasmodial proteins for in vitro characterization <xref ref-type="bibr" rid="pbio.1001138-He2">[25]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Odom1">[28]</xref>.</p>
      <p>Amongst the annotated apicoplast pathways, <italic>Plasmodium</italic> relies on the prokaryotic MEP/DOXP/non-mevalonate pathway for synthesizing isoprenoid precursors rather than the canonical mevalonate pathway used by most other eukaryotes and all mammals (including the human host) <xref ref-type="bibr" rid="pbio.1001138-Jomaa1">[29]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Rohmer1">[30]</xref>. Both pathways produce isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) as the final products, but the enzymes and chemical intermediates leading to synthesis of these compounds are entirely different. Fosmidomycin, an inhibitor of the MEP pathway, kills blood-stage parasites and has been tested in clinical trials as an antimalarial <xref ref-type="bibr" rid="pbio.1001138-Wiesner1">[31]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Oyakhirome1">[32]</xref>. Inhibition by fosmidomycin suggests that isoprenoid precursor biosynthesis is essential in blood-stage infection, although the possibility of off-pathway targets as the cause of the drug effect (as was found to be the case for triclosan) has not been ruled out <xref ref-type="bibr" rid="pbio.1001138-Jomaa1">[29]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Dharia1">[33]</xref>. Furthermore, IPP and DMAPP are not an end onto themselves but rather building blocks used to synthesize small molecule isoprenoids with a host of functions or C<sub>15</sub>/C<sub>20</sub> prenyl chains for the post-translational modification of proteins <xref ref-type="bibr" rid="pbio.1001138-Dewick1">[34]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Nguyen1">[35]</xref>. Once IPP and DMAPP are exported into the parasite cytoplasm, the downstream isoprenoid products in <italic>Plasmodium</italic> and their function during infection are unknown.</p>
      <p>The significance of isoprenoid precursor biosynthesis as a drug target and gateway for identifying isoprenoid products with essential functions in pathogenesis depends on a clear demonstration of its role in parasite survival. In addition to its essentiality, this pathway may represent the only direct output from the apicoplast into the cytoplasm during blood stage growth since the remaining annotated pathways function primarily for organelle maintenance, support the mitochondria, or are not essential in this stage. Given the difficulty of studying the apicoplast by traditional methods, we employed an alternative strategy using drug inhibition/chemical rescue, equivalent to genetic deletion/complementation, to establish pathway essentiality and sufficiency. Using this simple chemical genetic approach, we show that isoprenoid precursor biosynthesis is not only essential but in fact the sole essential function of the apicoplast during blood-stage growth.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>Isoprenoid Precursors Chemically Rescue Fosmidomycin Inhibition</title>
        <p>To investigate the specificity of fosmidomycin for the isoprenoid precursor biosynthetic pathway, we observed the effect of supplementation with isoprenoid precursors, IPP and DMAPP, on drug inhibition of blood-stage parasites. Growth inhibition of blood-stage <italic>P. falciparum</italic> W2 by fosmidomycin occurred with an EC<sub>50</sub> = 0.98 µM (95% confidence interval = 0.93–1.03 µM; <xref ref-type="fig" rid="pbio-1001138-g001">Figure 1A</xref>). When drug susceptibility was performed in media supplemented with 200 µM IPP, DMAPP, or both IPP and DMAPP, only IPP (without DMAPP) was sufficient to completely reverse the growth inhibition in the presence of up to 100 µM fosmidomycin (<xref ref-type="fig" rid="pbio-1001138-g001">Figure 1A</xref>). Survival of parasites was dependent on the concentration of IPP in the media with rescue apparent at 200 µM IPP (<xref ref-type="fig" rid="pbio-1001138-g001">Figure 1B</xref>). DMAPP alone or in combination with IPP had no effect or was even slightly toxic (<xref ref-type="fig" rid="pbio-1001138-g001">Figure 1A</xref>). Addition of up to 2 mM 3-methyl-3-butenol, the alcohol analog of IPP lacking the pyrophosphate moiety, alone or in combination with 3-methyl-2-butenol, the alcohol analog of DMAPP, also did not rescue fosmidomycin inhibition (<xref ref-type="supplementary-material" rid="pbio.1001138.s001">Figure S1</xref>). Finally, reversal of drug inhibition by addition of IPP was only seen with fosmidomycin and did not occur with chloroquine, a drug that does not target isoprenoid precursor biosynthesis (<xref ref-type="supplementary-material" rid="pbio.1001138.s002">Figure S2</xref>). These findings establish that (1) fosmidomycin inhibition is specific for the isoprenoid precursor biosynthetic pathway, (2) isoprenoid precursor biosynthesis is essential for blood-stage <italic>P. falciparum</italic>, and (3) exogenous IPP fulfills endogenous biosynthetic function.</p>
        <fig id="pbio-1001138-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.1001138.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Chemical rescue of fosmidomycin inhibition with IPP precursors.</title>
            <p>(A) Growth inhibition by fosmidomycin (0–100 µM) in media supplemented with 200 µM IPP, DMAPP, or both IPP and DMAPP. (B) Concentration dependence of IPP rescue.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.g001" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2b">
        <title>IPP Supplementation Rescues Antibiotic-Induced Delayed Death</title>
        <p>To determine whether rescue of the isoprenoid precursor biosynthesis pathway can reverse delayed death due to antibiotics, <italic>P. falciparum</italic> W2 parasites were treated with chloramphenicol, clindamycin, or doxycycline in the presence of IPP. As described above, treatment of blood-stage parasites with these prokaryotic transcription and translation inhibitors specifically blocks apicoplast gene expression in the first 48 h cycle leading to apicoplast loss and parasite death in the second cycle <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Dahl2">[15]</xref>. As such, antibiotic treatment yielded a 48 h EC<sub>50</sub> in growth assays due to nonspecific inhibition and a lower 96 h EC<sub>50</sub> due to apicoplast-specific inhibition (<xref ref-type="table" rid="pbio-1001138-t001">Table 1</xref>). This shift in the EC<sub>50</sub> values from 48 to 96 h is characteristic of the delayed death phenotype. By supplementing with 200 µM IPP, reversal of apicoplast-specific inhibition at 96 h by all drugs was observed with EC<sub>50</sub> values reflective of only nonspecific drug effects. In fact, when addition of IPP was compared from 48–96 h or 0–96 h, IPP was only required during the second cycle consistent with a deficiency in the <italic>progeny</italic> of treated parasites (<xref ref-type="table" rid="pbio-1001138-t001">Table 1</xref>). Similar results were demonstrated with <italic>P. falciparum</italic> D10 strain, suggesting that the rescue of antibiotic inhibition by IPP is not strain-specific (<xref ref-type="table" rid="pbio-1001138-t001">Table 1</xref>).</p>
        <table-wrap id="pbio-1001138-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001138.t001</object-id><label>Table 1</label><caption>
            <title>Rescue of apicoplast-specific growth inhibition by antibiotics.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pbio-1001138-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.t001" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Strain</td>
                <td align="left" colspan="1" rowspan="1">Drug</td>
                <td align="left" colspan="5" rowspan="1">EC<sub>50</sub> (µM)<xref ref-type="table-fn" rid="nt102">a</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="2" rowspan="1">48 h</td>
                <td align="left" colspan="3" rowspan="1">96 h</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1"/>
                <td align="left" colspan="1" rowspan="1">No Rescue</td>
                <td align="left" colspan="1" rowspan="1">+IPP</td>
                <td align="left" colspan="1" rowspan="1">No Rescue</td>
                <td align="left" colspan="1" rowspan="1">+IPP 0–96 h</td>
                <td align="left" colspan="1" rowspan="1">+IPP 48–96 h</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <bold>W2</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">
                  <bold>Chloramphenicol</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">13.7 (9.7–19.4)</td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <bold>W2</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">
                  <bold>Clindamycin</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">&gt;10<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">&gt;10<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">0.004 (0.002–0.006)</td>
                <td align="left" colspan="1" rowspan="1">&gt;10<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">ND</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <bold>W2</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">
                  <bold>Doxycycline</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">4.9 (2.9–8.5)</td>
                <td align="left" colspan="1" rowspan="1">5.1 (2.3–11.0)</td>
                <td align="left" colspan="1" rowspan="1">0.3 (0.2–0.4)</td>
                <td align="left" colspan="1" rowspan="1">3.2 (2.6–3.9)</td>
                <td align="left" colspan="1" rowspan="1">ND</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <bold>D10</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">
                  <bold>Chloramphenicol</bold>
                </td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">19.8 (13.6–28.8)</td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
                <td align="left" colspan="1" rowspan="1">&gt;300<xref ref-type="table-fn" rid="nt103">b</xref></td>
              </tr>
            </tbody>
          </table></alternatives><table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>ND, not determined.</p>
            </fn>
            <fn id="nt102">
              <label>a</label>
              <p>Represented as mean (95% confidence interval).</p>
            </fn>
            <fn id="nt103">
              <label>b</label>
              <p>50% inhibition above highest assayed concentration.</p>
            </fn>
          </table-wrap-foot></table-wrap>
        <p>Blood-stage parasites were carried through several life cycles with simultaneous antibiotic treatment and IPP rescue to determine (1) any significant growth defects and (2) the dependence on further supplementation with IPP (after removal of the antibiotic) of the surviving parasites. As shown in <xref ref-type="fig" rid="pbio-1001138-g002">Figure 2A</xref>, the doxycycline-treated, IPP-rescued strain showed parasitemia ≥65% of that seen in the untreated strain throughout the treatment/rescue course. (Given the narrow concentration range between apicoplast-specific and nonspecific inhibition for doxycycline, some decreased growth due to non-specific inhibitory effects is expected at the drug concentration used.) Moreover, the rescued strain was carried for a total of 26 days with IPP supplementation but in the absence of antibiotics with no diminishment in growth capacity. In contrast, doxycycline-treated parasites without added IPP quickly died after the 2<sup>nd</sup> cycle of treatment with undetectable parasitemia by the end of the 3<sup>rd</sup> cycle (<xref ref-type="fig" rid="pbio-1001138-g002">Figure 2A</xref>). Significantly, removal of IPP and doxycycline from the media at the start of the 4<sup>th</sup> cycle results in a rapid decline in parasitemia of the rescued parasites (<xref ref-type="fig" rid="pbio-1001138-g002">Figure 2A</xref>). With further passage in media lacking both IPP and doxycycline, the parasitemia of rescued parasites became undetectable. Again similar results could be demonstrated with <italic>P. falciparum</italic> D10 strain or treatment with chloramphenicol (<xref ref-type="supplementary-material" rid="pbio.1001138.s003">Figures S3</xref> and <xref ref-type="supplementary-material" rid="pbio.1001138.s004">S4</xref>). These results show that antibiotic-treated parasites rescued by IPP supplementation have no gross growth defect but are entirely dependent on exogenous IPP for continued growth. We cannot rule out more subtle growth defects that would be difficult to assess by comparison of parallel cultures.</p>
        <fig id="pbio-1001138-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.1001138.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Rescue of antibiotic delayed death and apicoplast genome loss.</title>
            <p>(A) Survival of parasites over 4 life cycles treated with (1) doxycyline only, (2) doxycycline+IPP, or (3) doxycycline+IPP for three cycles followed by removal of both. Parasitemia is normalized to that of an untreated control. (B) Apicoplast∶nuclear and (C) mitochondria∶nuclear genome ratio of doxycycline only and doxycycline+IPP treated parasites over the same time course. Genome ratios are normalized to an untreated control. Data from three separate passages are shown.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.g002" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2c">
        <title>Antibiotic-Treated, IPP-Rescued Parasites Lose Their Apicoplast Genome</title>
        <p>IPP rescue of death following antibiotic treatment could be due to either (1) blocking the deleterious effects of antibiotic treatment to cause apicoplast loss or (2) compensating for the loss of the apicoplast. The irreversible dependence of the rescued parasites on IPP (even after removal of the antibiotic) suggests the latter—that apicoplast loss occurs but is chemically complemented by exogenous IPP. We sought to confirm whether the sequelae of apicoplast dysfunction that occurs following treatment with antibiotics (reviewed above) also bears out in IPP-rescued parasites <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>. A hallmark of organelle dysfunction is the loss of the apicoplast genome <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Fichera1">[16]</xref>. We used quantitative PCR for target genes on the apicoplast, mitochondria, and nuclear genomes to monitor the ratio of organelle: nuclear genomes during the course of antibiotic treatment and chemical rescue. <xref ref-type="fig" rid="pbio-1001138-g002">Figure 2B</xref> demonstrates a marked decline in the apicoplast∶nuclear genome ratio after the 2<sup>nd</sup> cycle in all antibiotic-treated parasites regardless of supplementation with IPP. At the end of the 4<sup>th</sup> cycle, the ratio is reduced by at least 100-fold. In contrast, no such decline is noted in the mitochondria∶nuclear genome ratio (<xref ref-type="fig" rid="pbio-1001138-g002">Figure 2C</xref>). Rescued strains carried out for a total of 26 days continued to show undetectable apicoplast genome and detectable mitochondria and nuclear genomes. Thus, IPP-rescued parasites undergo a specific and irreversible loss of the apicoplast genome without concomitant loss of the nuclear or mitochondrial genomes, yet these parasites continue to be viable.</p>
      </sec>
      <sec id="s2d">
        <title>Antibiotic-Treated, IPP-Rescued Parasites Lose Protein Import Function</title>
        <p>A critical function of the apicoplast, required for the maintenance of its proteome, is the import of nuclear-encoded proteins into the organelle. A bipartite <italic>N</italic>-terminal sequence consisting of a signal sequence and a transit peptide is required to target proteins to the organelle <xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. Upon import into the apicoplast, the transit peptide is cleaved to produce a mature protein <xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. Protein processing is therefore a marker of successful protein import into the apicoplast. We used a transgenic D10 strain expressing GFP fused to an <italic>N</italic>-terminal apicoplast targeting sequence (ACP<sub>L</sub>-GFP) to assess apicoplast protein processing during the course of antibiotic treatment and IPP rescue <xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. The 33 kDa full-length GFP was cleaved to produce a predominant 30 kDa mature protein in untreated parasites (<xref ref-type="fig" rid="pbio-1001138-g003">Figure 3A</xref>). Parasites treated with doxycycline only began to lose protein processing function during the 2<sup>nd</sup> cycle as seen in the increased accumulation of full-length protein at 96 h but do not survive beyond this cycle (<xref ref-type="fig" rid="pbio-1001138-g003">Figure 3B</xref>). When doxycycline treatment was rescued with IPP, surviving parasites showed successive loss of protein processing with each treatment cycle such that only preprocessed GFP was detectable at 144 h, the start of the 4<sup>th</sup> cycle (<xref ref-type="fig" rid="pbio-1001138-g003">Figure 3C</xref>). A smaller, previously described degradation band also became apparent in the rescued parasites <xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. The absence of protein processing activity indicates a loss of the critical protein import function of the apicoplast in these rescued parasites.</p>
        <fig id="pbio-1001138-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.1001138.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Loss of protein processing of apicoplast-targeted proteins in antibiotic-treated, rescued parasites.</title>
            <p>Immunoblot using anti-GFP shows a time course of apicoplast-dependent protein processing of apicoplast-targeted GFP in (A) untreated, (B) doxycycline-treated, and (C) doxycycline+IPP treated parasites.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.g003" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2e">
        <title>Antibiotic-Treated, IPP-Rescued Parasites Lack an Apicoplast</title>
        <p>The final outcome of antibiotic treatment is a failure of apicoplast replication and segregation during cell division, resulting in loss of the organelle and death <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>. The loss of the genome and protein import function strongly suggests that parasites that survive antibiotic treatment are in fact apicoplast-minus. Localization of GFP in the D10 ACP<sub>L</sub>-GFP strain was used to visualize the apicoplast. As expected, GFP localizes to a discrete structure in the parasite in untreated cells (<xref ref-type="fig" rid="pbio-1001138-g004">Figure 4</xref> and <xref ref-type="supplementary-material" rid="pbio.1001138.s008">Video S1</xref>). In contrast, in parasites that have been rescued from antibiotic death, GFP loses this discrete apicoplast localization and becomes diffuse (<xref ref-type="fig" rid="pbio-1001138-g004">Figure 4</xref>). Confocal images show that numerous foci of GFP are scattered throughout the cytoplasm (<xref ref-type="fig" rid="pbio-1001138-g004">Figure 4</xref> and <xref ref-type="supplementary-material" rid="pbio.1001138.s009">Video S2</xref>). The largest foci measure &gt;200 nm, so these collections of GFP are less likely to be cytoplasmic protein aggregates but instead may represent vesicles containing protein. Combined with the absence of the apicoplast genome and protein import function, the loss of GFP localization indicates the absence of the apicoplast itself to which it is normally targeted.</p>
        <fig id="pbio-1001138-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pbio.1001138.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Loss of localization of apicoplast-targeted proteins in antibiotic-treated, rescued parasites.</title>
            <p>Widefield epifluorescence microscopy for apicoplast (ACP<sub>L</sub>-GFP) and nucleus (Hoescht 33342) comparing ring, trophozoite, and schizont in untreated parasites and chloramphenicol+IPP treated parasites. To right, confocal 3-D reconstruction of untreated parasites and chloramphenicol+IPP treated early trophozoite stage parasites.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.g004" xlink:type="simple"/>
        </fig>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>Until now, the mystery of apicoplast function has been a critical gap in our understanding of malaria pathogenesis. Our findings demonstrate that the production of isoprenoid precursors is the only essential function of the apicoplast during asexual blood-stage <italic>P. falciparum</italic> growth (<xref ref-type="fig" rid="pbio-1001138-g005">Figure 5</xref>). This surprising revelation has several important implications and invites a host of new questions. Because isoprenoid precursors are building blocks to synthesize cellular isoprenoid products with diverse functions, their key role now gives added urgency to the elucidation of these products and their downstream functions. At least one essential prenylated product is ubiquinone, a component of the mitochondrial electron transport chain. There are certainly other essential, as-yet-unidentified isoprenoid products since transgenic parasites which express yeast dihydroorotic acid dehydrogenase and no longer require their electron transport chain are still susceptible to fosmidomycin and antibiotics and could be rescued with IPP supplementation (unpublished data) <xref ref-type="bibr" rid="pbio.1001138-Painter1">[36]</xref>. Possible isoprenoid products include dolichols involved in protein <italic>N</italic>-glycosylation which have been detected in <italic>Plasmodium</italic> and prenylated proteins, such as Rab homologs required for vesicular trafficking and a recently identified tyrosine phosphatase <xref ref-type="bibr" rid="pbio.1001138-Couto1">[37]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Pendyala1">[41]</xref>.</p>
      <fig id="pbio-1001138-g005" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pbio.1001138.g005</object-id>
        <label>Figure 5</label>
        <caption>
          <title>Model of apicoplast function.</title>
          <p>(Top) The essential function of the apicoplast is the production of isoprenoid precursors, IPP and DMAPP, which are exported into the cytoplasm and used to synthesize small molecule isoprenoids and prenylated proteins. Parasites that are unable to synthesize isoprenoid precursors either due to inhibition of the biosynthetic pathway by fosmidomycin or loss of the apicoplast following doxycycline inhibition can be chemically rescued by addition of exogenous IPP (red). The exogenous IPP enters the host cell through unknown membrane transporters and fulfills the missing biosynthetic function. (Bottom) Reaction scheme for MEP pathway biosynthesis of IPP and DMAPP with the enzymatic step inhibited by fosmidomycin indicated.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.g005" xlink:type="simple"/>
      </fig>
      <p>The current findings also imply that several annotated apicoplast pathways are in fact non-essential. Amongst both identified pathways and the 70% of apicoplast gene products with unknown function, only isoprenoid precursor biosynthesis and any pathways supporting this function in blood-stage parasites (including those required for organelle maintenance and replication) are essential and therefore viable apicoplast drug targets <xref ref-type="bibr" rid="pbio.1001138-Ralph1">[20]</xref>. Assertions that type II fatty acid and, by implication, acetyl-CoA biosynthesis were essential apicoplast functions during blood-stage growth have already been disproven <xref ref-type="bibr" rid="pbio.1001138-Yu1">[23]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Vaughan1">[24]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Pei1">[42]</xref>. A parasite-derived pathway for heme biosynthesis contains steps that occur in the apicoplast, mitochondria, and cytosol. Our results strongly imply that blood-stage parasites do not depend on de novo heme biosynthesis using this pathway but instead rely on an extrinsic de novo pathway utilizing imported host enzymes or salvage of heme from the host by an unidentified mechanism <xref ref-type="bibr" rid="pbio.1001138-Bonday1">[43]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Dhanasekaran1">[44]</xref>. Still other pathways such as Fe-S cluster biosynthesis supply cofactors for enzymes within the organelle but are not exported outside the organelle. These pathways become “non-essential” when the need for organelle maintenance is removed.</p>
      <p>The complexity of the organelle and the simplicity of its blood-stage function pose an obvious contradiction. Approximately 5%–10% of the <italic>Plasmodium</italic> genome is predicted to encode apicoplast-targeted gene products (although the localization and/or function of the majority of these gene products have not been validated) <xref ref-type="bibr" rid="pbio.1001138-Ralph1">[20]</xref>. In order to import these proteins into the apicoplast, parasites utilize a dedicated protein trafficking pathway <xref ref-type="bibr" rid="pbio.1001138-Waller1">[7]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. In addition, the organelle undergoes complex morphological development during blood stage growth, requiring cellular machinery to faithfully replicate and segregate the organelle at every cell division <xref ref-type="bibr" rid="pbio.1001138-Stanway1">[10]</xref>. Why are such huge resources consumed to maintain a single essential function? First, while the function of the apicoplast is limited during the blood stage, the need for more extensive organelle function during other developmental stages may dictate its maintenance in intraerythrocytic parasites as the organelle cannot be generated de novo. Fatty acid biosynthesis, for example, is an essential apicoplast function in liver stage parasites <xref ref-type="bibr" rid="pbio.1001138-Yu1">[23]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Vaughan1">[24]</xref>. Second, <italic>Plasmodium</italic> may have been evolutionarily trapped in its bondage to the apicoplast. Having acquired the plastid early in its evolution, it may have been unable to dispense of it even after adopting an increasingly parasitic lifestyle due to the transfer of even a few essential functions to the organelle. In any case, this imbalance emphasizes the value of targeting housekeeping pathways involved in organelle maintenance and replication to interfere with its function.</p>
      <p>An important consideration is whether our findings accurately reflect in vivo growth requirements of parasites during infection. Specifically, are there essential metabolites supplemented in culture which could not be acquired during in vivo growth and instead must be biosynthesized by the apicoplast? While parasitized RBCs during infection use human plasma as a source of extracellular nutrients, our cultures were grown in RPMI medium 1640 supplemented with purified serum substitute, Albumax. We found that Albumax could be replaced with 10% human serum with no effect on the survival of apicoplast-minus parasites in the presence of IPP (<xref ref-type="supplementary-material" rid="pbio.1001138.s005">Figure S5</xref>). RPMI medium contains salts, 20 amino acids, 11 vitamins, 4 other organic molecules, and glucose. The acquisition and biosynthesis of these nutrients by blood-stage <italic>Plasmodium</italic> and their essentiality for intraerythrocytic growth based on available evidence is shown in <xref ref-type="supplementary-material" rid="pbio.1001138.s007">Table S1</xref>. In general, blood-stage <italic>Plasmodium</italic> biosynthesizes very limited amounts of just 3 amino acids and is dependent on amino acids from either (1) hemoglobin degradation or (2) acquisition from patient plasma through newly established permeation pathways in the infected red cell <xref ref-type="bibr" rid="pbio.1001138-Sherman1">[45]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Liu1">[47]</xref>. Similarly, current knowledge of <italic>Plasmodium</italic> metabolism also suggests that the remaining organic metabolites found in RPMI medium are biosynthesized by non-apicoplast pathways or can be acquired from the host red cell or patient plasma <xref ref-type="bibr" rid="pbio.1001138-Kirk1">[46]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Divo1">[48]</xref>–<xref ref-type="bibr" rid="pbio.1001138-Mller1">[50]</xref>. Consequently, we believe that our findings can be extrapolated to in vivo requirements for the apicoplast to support parasite growth and development. At the very least, our results define a very minimal set of potential metabolites (IPP and components found in RPMI 1640 medium) that could be biosynthesized in the apicoplast. We cannot, however, rule out additional apicoplast functions (other than those required for growth) that would not be revealed in our blood culture system, such as functions required for immune evasion.</p>
      <p>Several aspects of the chemical rescue with isoprenoid precursors are notable. During chemical rescue, exogenous IPP could enter the parasite through permeation pathways established in the parasitized erythrocyte or other uncharacterized membrane transporters <xref ref-type="bibr" rid="pbio.1001138-Kirk1">[46]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Ginsburg1">[51]</xref>. The RBC is largely metabolically inactive and unlikely to have significant ongoing isoprenoid precursor biosynthesis via the host mevalonate pathway or stores of these metabolites <xref ref-type="bibr" rid="pbio.1001138-Wiback1">[52]</xref>. It is also unlikely that these high-energy pyrophosphorylated molecules would accumulate to appreciable levels in plasma (200 µM was required for rescue in our experiments). Consistent with this notion, IPP was not present in the Serum Metabolome Database (SMDB), which contains 4,229 detectable metabolites <xref ref-type="bibr" rid="pbio.1001138-Psychogios1">[53]</xref>. Therefore, acquisition of isoprenoid precursors in vivo by salvage of IPP from infected blood is improbable. Once in the parasite, exogenous IPP may fulfill its function in the cytoplasm with or without uptake into the apicoplast <xref ref-type="bibr" rid="pbio.1001138-Brooks1">[54]</xref>.</p>
      <p>Although both IPP and DMAPP are required to synthesize isoprenoid products, supplementation with IPP alone is sufficient to fulfill endogenonous isoprenoid precursor biosynthesis, implying the presence of an IPP isomerase in the cytoplasm that converts IPP to DMAPP. This activity may be important in establishing the optimal cellular ratio of IPP to DMAPP, as toxicity was noted with increasing DMAPP concentrations in our experiments. A putative IPP isomerase has been identified in the <italic>Plasmodium</italic> genome <xref ref-type="bibr" rid="pbio.1001138-Mohanty1">[55]</xref>. A recent report suggested that geranylgeraniol, the alcohol analog of a C<sub>20</sub> prenyl chain, could rescue fosmidomycin inhibition <xref ref-type="bibr" rid="pbio.1001138-Zhang1">[56]</xref>. We were unable to rescue fosmidomycin inhibition with alcohol analogs of IPP and DMAPP, indicating either poor cellular penetration of the alcohols or the absence of a kinase to convert the alcohol analogs to the pyrophosphorylated and active metabolites (<xref ref-type="supplementary-material" rid="pbio.1001138.s001">Figure S1</xref>). Even with conversion of geranylgeraniol to geranylgeranyl pyrophosphate in the cell, it would seem that a C<sub>5</sub> building block, such as IPP, would almost certainly be required to extend the supplemented C<sub>20</sub> unit for construction of polyprenyl chains, such as that found in ubiquinone, and to construct smaller prenyl chains, such as for protein farnesylation. The reported rescue with geranylgeraniol was performed at 1.5 µM fosmidomycin, which is above the concentration required for 50% growth inhibition but may be below that required for adequate inhibition of the biosynthetic pathway (since phenotypic growth inhibition can be apparent even at low levels of inhibition of the biosynthetic pathway) <xref ref-type="bibr" rid="pbio.1001138-Zhang1">[56]</xref>. Therefore, the reported results may be complicated by ongoing biosynthesis of IPP and DMAPP contributing to the precursor pool. Consistent with this, neither farnesol nor geranylgeraniol was able to rescue fosmidomycin concentrations &gt;10 µM, and both showed dose-related parasite toxicity (<xref ref-type="supplementary-material" rid="pbio.1001138.s006">Figure S6</xref>). In contrast, we were able to demonstrate IPP rescue at fosmidomycin concentrations exceeding 100 µM, well above its EC<sub>90</sub> for growth inhibition.</p>
      <p>The consequences of apicoplast loss following antibiotic treatment and IPP rescue are no less intriguing. In the parasites that survive antibiotic treatment by chemical rescue, the organelle is irreversibly lost when it fails to segregate to daughter cells <xref ref-type="bibr" rid="pbio.1001138-Dahl1">[9]</xref>. In these apicoplast-minus parasites, apicoplast gene products encoded in the nucleus may continue to be transcribed and translated. These products may properly shuttle into the secretory pathway but cannot be diverted to the organelle <xref ref-type="bibr" rid="pbio.1001138-Waller2">[8]</xref>. Based on the microscopy results, we hypothesize that proteins may be packaged into transport vesicles bound for the organelle but are unable to localize to the missing structure and therefore accumulate in the cytoplasm appearing as numerous foci. While we cannot rule out the presence of structural remnants of the apicoplast, the observed foci are unlikely to support apicoplast functions. Apicoplast-targeted proteins may require both cleavage of the long basic transit peptide and chaperones in the lumen of the apicoplast for proper folding. We observed that cleavage of the transit peptide from targeted proteins, a critical apicoplast function, does not occur in rescued parasites (<xref ref-type="fig" rid="pbio-1001138-g003">Figure 3C</xref>).</p>
      <p>The close physical and functional relationship between the apicoplast and the mitochondria raises the possibility that loss of the apicoplast might affect the ability of the mitochondria to replicate and divide. We were able to detect the mitochondrial genome by qPCR for the cytB3 gene and observe labeling of the mitochondria with Mitotracker by fluorescence microscopy in apicoplast-minus parasites (<xref ref-type="fig" rid="pbio-1001138-g002">Figure 2C</xref>; unpublished data). Despite the loss of the apicoplast, these parasites do appear to contain mitochondria.</p>
      <p>While the survival of apicoplast-minus <italic>P. falciparum</italic> invokes a slew of intriguing questions, these same parasites will be a powerful and indispensable tool for further dissection of apicoplast biology. Apicoplast-minus <italic>P. falciparum</italic> strains generated in this study can be used to assess organelle requirement during gametocytogenesis and mosquito stage development. These strains also provide novel avenues to identify isoprenoid products, generate conditional mutants of essential genes involved in apicoplast maintenance and replication, conduct metabolomic or proteomic profiling, and study protein trafficking to the organelle.</p>
      <p>With regard to drug development, our chemical rescue strategy also addresses the critical deficiency of current cell growth screening assays, namely lack of knowledge of the drug target. Candidate drug hits detected in phenotypic assays can be screened for chemical rescue of the growth inhibition. The reversal of growth inhibition by IPP supplementation specifically identifies inhibitors that target pathways involved in MEP pathway function, replication, or maintenance of the apicoplast, providing a pathway-specific drug screen to aid in discovery of new classes of anti-malarials. The ability to chemically complement the cell death phenotype will prevent false leads from off-target effects, like that seen with triclosan and its misconstrued effect on type II fatty acid biosynthesis <xref ref-type="bibr" rid="pbio.1001138-Surolia1">[22]</xref>.</p>
      <p>Finally, the apicoplast-minus strains dependent on IPP for continued growth are a unique and ideal candidate for an attenuated blood-stage vaccine <xref ref-type="bibr" rid="pbio.1001138-McCarthy1">[57]</xref>,<xref ref-type="bibr" rid="pbio.1001138-Good1">[58]</xref>. Unlike irradiated or drug-treated whole parasite vaccines, apicoplast-minus parasites would continue to develop in blood at most one cycle, including a single erythrocyte rupture and reinvasion, thereby stimulating a stronger immune response. However, judging by the effects of IPP withdrawal in culture, they would be unable to develop further in the absence of exogenous IPP (<xref ref-type="fig" rid="pbio-1001138-g002">Figure 2A</xref>). Lending support to this notion, a similar “limited survival” strategy targeting the apicoplast in liver-stage parasites has proven effective as a liver-stage vaccine candidate <xref ref-type="bibr" rid="pbio.1001138-Friesen1">[59]</xref>. A significant advantage of our approach is that attenuation is achieved chemically and does not require difficult or costly genetic manipulation (as is the case with genetically modified vaccine strains), thereby allowing for the possibility of incorporating circulating field strains of <italic>Plasmodium</italic> in a vaccine formulation <xref ref-type="bibr" rid="pbio.1001138-Vaughan2">[60]</xref>. There would also be very little risk of reversion as it would be extremely difficult to reacquire apicoplast function by mutation.</p>
      <p>In summary, we believe that the current study ushers in a new era in the investigation of the apicoplast in <italic>Plasmodium</italic> with exciting opportunities to counteract the malarial scourge on human lives.</p>
    </sec>
    <sec id="s4" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title><italic>P. falciparum</italic> Cultures</title>
        <p><italic>Plasmodium falciparum</italic> W2 (MRA-157), D10 (MRA-201), and D10 ACP<sub>L</sub>-GFP (MRA-568) were obtained from MR4. Parasites were grown in human erythrocytes (2% hematocrit) in RPMI 1640 media supplemented with 0.25% Albumax II (GIBCO Life Technologies), 2 g/L sodium bicarbonate, 0.1 mM hypoxanthine, 25 mM HEPES (pH 7.4), and 50 µg/L gentamycin, at 37°C, 5% O<sub>2</sub>, and 6% CO<sub>2</sub>. For D10 ACP<sub>L</sub>-GFP, the media was also supplemented with 100 nM pyrimethamine (Sigma).</p>
        <p>For passage of antibiotic-treated, IPP-rescued parasites, the media was supplemented with 1.5–2 µM doxycycline or 50 µM chloramphenicol. 48 h after initiation of antibiotic treatment, rescued strains were supplemented with 200 µM IPP (Isoprenoids LC) for continuous passage. For comparison of growth between different treatment conditions, cultures were carried simultaneously and handled identically with respect to media changes and addition of blood cells.</p>
      </sec>
      <sec id="s4b">
        <title>Drug Susceptibility Assays</title>
        <p>Growth assays were performed in 96-well plates containing serial dilution of drugs in duplicate or triplicate. Media was supplemented with IPP or DMAPP as indicated. To determine the EC<sub>50</sub> of fosmidomycin (Invitrogen), growth was initiated with ring-stage parasites (synchronized with 2.5% sorbitol treatment 48 h prior) at 1% parasitemia (0.5%–2% hematocrit). Plates were incubated for 72 h. To determine the EC<sub>50</sub> of antibiotics at 48 h, growth was initiated at 1% parasitemia and incubated for 48 h. To determine the EC<sub>50</sub> of antibiotics at 96 h and observe the delayed death phenotype, cultures were initiated at 0.2% parasitemia, 75% of the media was exchanged at 48 h, and plates were incubated for an additional 48 h (total 96 h). For all assays, growth was terminated by fixation with 1% formaldehyde and parasitized cells were stained with 50 nM YOYO-1 (Invitrogen). Parasitemia was determined by flow cytometry. Data were analyzed by FlowJo, and EC<sub>50</sub> curves plotted by GraphPad Prism.</p>
      </sec>
      <sec id="s4c">
        <title>Quantitative Real-Time PCR</title>
        <p>Parasites from 200 µL of culture were isolated by saponin lysis followed by PBS wash to remove extracellular DNA. DNA was purified using QiaAMP blood kits (Qiagen). Primers were designed to target genes found on each organelle or nuclear genome: <italic>tufA</italic> (apicoplast) <named-content content-type="gene" xlink:type="simple">5′-GATATTGATTCAGCTCCAGAAGAAA-3′</named-content> / <named-content content-type="gene" xlink:type="simple">5′-ATATCCATTTGTGTGGCTCCTATAA-3′</named-content>, <italic>cytb3</italic> (mitochondria) <named-content content-type="gene" xlink:type="simple">5′-AGATACATGCACGCAACAGG-3′</named-content> / <named-content content-type="gene" xlink:type="simple">5′-TCATTTGACCCCATGGTAAGA-3′</named-content>, and <italic>CHT1</italic> (nuclear) <named-content content-type="gene" xlink:type="simple">5′-TGTTTCCTTCAACCCCTTTT-3′</named-content> / <named-content content-type="gene" xlink:type="simple">5′-TGTTTCCTTCAACCCCTTTT-3′</named-content>. Reactions contained template DNA, 0.15 µM of each primer, and 0.75× LightCycler 480 SYBR Green I Master mix (Roche). PCR reactions were performed at 56°C primer annealing and 65°C template extension for 35 cycles on a Lightcycler 6500 (Roche). Relative quantification of target genes was determined using the method of Pfaffl <xref ref-type="bibr" rid="pbio.1001138-Pfaffl1">[61]</xref>. For each time point, the organelle∶nuclear genome ratio of the antibiotic-treated control or antibiotic-treated, IPP-rescued experiment was calculated relative to that of an untreated control collected at the same time.</p>
      </sec>
      <sec id="s4d">
        <title>Immunoblot</title>
        <p>Ring-stage D10 ACP<sub>L</sub>-GFP parasites from 1 mL of culture were isolated by saponin lysis, washed with PBS, and resuspended in 1×NuPAGE LDS sample buffer (Invitrogen). Proteins were separated by electrophoresis on 12% Bis-Tris gel (Invitrogen) and transferred to nitrocellulose membrane. After blocking, membranes were probed with 1∶1,000 polyclonal rabbit anti-GFP (Clontech) antibody and 1∶15,000 Alexa Fluor 810-conjugated anti-rabbit IgG secondary antibody (Invitrogen). Fluorescent antibody-bound proteins were detected with Odyssey Imager at 800 nm (LiCor Biosciences).</p>
      </sec>
      <sec id="s4e">
        <title>Fluorescence Microscopy</title>
        <p>Untreated and antibiotic treated/IPP rescued D10 ACP<sub>L</sub>-GFP parasites were incubated in 2 µg/mL Hoescht 33342 stain for 30 min at 37°C. Cells in culture media were settled onto 35 mm glass-bottom petri dishes (MakTek) coated with 1% polyethylenimine (Sigma). Widefield epifluorescence live cell images were obtained on a Nikon Eclipse Ti-E equipped with a Coolsnap HQ2 camera (Photometrics) using a 100×/1.4 oil immersion objective. Confocal live cell images were obtained on an A1 confocal mounted on a Nikon Eclipse Ti-E using a 60×/1.4 oil immersion objective. Images were analyzed by NIS-Elements software (Nikon).</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pbio.1001138.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>Fosmidomycin rescue with methylbutenols. Chemical rescue of fosmidomycin inhibition in media supplemented with 0–2 mM 3-methyl-3-butenol (IPP alcohol analog) or 0–2.25 mM 3- and 2-methyl-3-butenol (IPP and DMAPP alcohol analogs).</p>
          <p>(TIFF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s002" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p>IPP rescue of chloroquine inhibition. Chemical rescue of chloroquine inhibition (0–20 µM) in media supplemented with 200 µM IPP.</p>
          <p>(TIFF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s003" xlink:type="simple">
        <label>Figure S3</label>
        <caption>
          <p>Rescue of antibiotic delayed death in strain D10. Survival of D10 parasites over a time course of treatment with chloramphenicol only, chloramphenicol+IPP, and chloramphenicol+IPP for 3 cycles followed by removal of both. Parasitemia is normalized to that of an untreated control. Data from a single experiment are shown.</p>
          <p>(TIFF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s004" xlink:type="simple">
        <label>Figure S4</label>
        <caption>
          <p>Rescue of antibiotic delayed death and apicoplast genome loss with chloramphenicol treatment in strain W2. (A) Survival of W2 parasites over a time course of treatment with chloramphenicol only, chloramphenicol+IPP, and chloramphenicol+IPP for 3 cycles followed by removal of both. Parasitemia is normalized to that of an untreated control. (B) Apicoplast∶nuclear and (C) mitochondria∶nuclear genome ratio of chloramphenicol only and chloramphenicol+IPP treated parasites over the same time course. Genome ratios are normalized to an untreated control. Data from experiments carried out in triplicate are shown.</p>
          <p>(TIFF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s005" xlink:type="simple">
        <label>Figure S5</label>
        <caption>
          <p>Survival of antibiotic-treated, IPP-rescued parasites in media supplemented with 10% human serum. Untreated and antibiotic-treated, IPP-rescued W2 parasites were initially grown in media containing Albumax. Each culture was washed and then split into two cultures, which were resuspended in RPMI media supplemented with either 0.25% Albumax or 10% human serum at a starting parasitemia of 1%–2%. Parasitemia was determined by 200-cell counts of Giemsa-stained blood smears. Growth of the 10% serum culture is shown relative to that of the Albumax culture for both untreated and rescued strains. Data from a single experiment are shown.</p>
          <p>(TIFF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s006" xlink:type="simple">
        <label>Figure S6</label>
        <caption>
          <p>Fosmidomycin rescue with farnesol and geranylgeraniol. Chemical rescue of fosmidomycin inhibition in media supplemented with 0–500 µM farnesol or geranylgeraniol.</p>
          <p>(TIFF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s007" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s007" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>Components of RPMI Medium 1640 (Invitrogen), their plasma concentration, and evidence for their acquisition or biosynthesis by blood-stage <italic>Plasmodium</italic>.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s008" mimetype="video/x-m4v" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s008" xlink:type="simple">
        <label>Video S1</label>
        <caption>
          <p>Movie showing 360° rotation of confocal images of untreated ACP<sub>L</sub>-GFP parasites shown in <xref ref-type="fig" rid="pbio-1001138-g004">Figure 4</xref>.</p>
          <p>(M4V)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pbio.1001138.s009" mimetype="video/x-m4v" position="float" xlink:href="info:doi/10.1371/journal.pbio.1001138.s009" xlink:type="simple">
        <label>Video S2</label>
        <caption>
          <p>Movie showing 360° rotation of confocal images of chloramphenicol+IPP treated ACP<sub>L</sub>-GFP parasites shown in <xref ref-type="fig" rid="pbio-1001138-g004">Figure 4</xref>.</p>
          <p>(M4V)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We are grateful to Dr. Akhil Vaidya for providing <italic>P. falciparum</italic> strain D10 yDHOD and Dr. Geoff McFadden for depositing <italic>P. falciparum</italic> strain D10 ACP<sub>L</sub>-GFP in the MR4 collection. We also thank Alice Thwin (UCSF Nikon Imaging Center) for assistance with microscopy and Emily Wilson for technical assistance.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pbio.1001138-Wilson1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>R. J</given-names></name><name name-style="western"><surname>Denny</surname><given-names>P. W</given-names></name><name name-style="western"><surname>Preiser</surname><given-names>P. R</given-names></name><name name-style="western"><surname>Rangachari</surname><given-names>K</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>K</given-names></name><etal/></person-group>             <year>1996</year>             <article-title>Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum.</article-title>             <source>J Mol Biol</source>             <volume>261</volume>             <fpage>155</fpage>             <lpage>172</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-McFadden1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>McFadden</surname><given-names>G. I</given-names></name><name name-style="western"><surname>Reith</surname><given-names>M. E</given-names></name><name name-style="western"><surname>Munholland</surname><given-names>J</given-names></name><name name-style="western"><surname>Lang-Unnasch</surname><given-names>N</given-names></name></person-group>             <year>1996</year>             <article-title>Plastid in human parasites.</article-title>             <source>Nature</source>             <volume>381</volume>             <fpage>482</fpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Khler1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Köhler</surname><given-names>S</given-names></name><name name-style="western"><surname>Delwiche</surname><given-names>C. F</given-names></name><name name-style="western"><surname>Denny</surname><given-names>P. W</given-names></name><name name-style="western"><surname>Tilney</surname><given-names>L. G</given-names></name><name name-style="western"><surname>Webster</surname><given-names>P</given-names></name><etal/></person-group>             <year>1997</year>             <article-title>A plastid of probable green algal origin in Apicomplexan parasites.</article-title>             <source>Science</source>             <volume>275</volume>             <fpage>1485</fpage>             <lpage>1489</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Dondorp1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dondorp</surname><given-names>A. M</given-names></name><name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name><name name-style="western"><surname>Yi</surname><given-names>P</given-names></name><name name-style="western"><surname>Das</surname><given-names>D</given-names></name><name name-style="western"><surname>Phyo</surname><given-names>A. P</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Artemisinin resistance in Plasmodium falciparum malaria.</article-title>             <source>New England Journal of Medicine</source>             <volume>361</volume>             <fpage>455</fpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Fast1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Fast</surname><given-names>N. M</given-names></name><name name-style="western"><surname>Kissinger</surname><given-names>J. C</given-names></name><name name-style="western"><surname>Roos</surname><given-names>D. S</given-names></name><name name-style="western"><surname>Keeling</surname><given-names>P. J</given-names></name></person-group>             <year>2001</year>             <article-title>Nuclear-encoded, plastid-targeted genes suggest a single common origin for apicomplexan and dinoflagellate plastids.</article-title>             <source>Mol Biol Evol</source>             <volume>18</volume>             <fpage>418</fpage>             <lpage>426</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Janoukovec1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Janouškovec</surname><given-names>J</given-names></name><name name-style="western"><surname>Horák</surname><given-names>A</given-names></name><name name-style="western"><surname>Oborník</surname><given-names>M</given-names></name><name name-style="western"><surname>Lukeš</surname><given-names>J</given-names></name><name name-style="western"><surname>Keeling</surname><given-names>P. J</given-names></name></person-group>             <year>2010</year>             <article-title>A common red algal origin of the apicomplexan, dinoflagellate, and heterokont plastids.</article-title>             <source>Proc Natl Acad Sci</source>             <volume>107</volume>             <fpage>10949</fpage>             <lpage>10954</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Waller1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Waller</surname><given-names>R. F</given-names></name><name name-style="western"><surname>Keeling</surname><given-names>P. J</given-names></name><name name-style="western"><surname>Donald</surname><given-names>R. G. K</given-names></name><name name-style="western"><surname>Striepen</surname><given-names>B</given-names></name><name name-style="western"><surname>Handman</surname><given-names>E</given-names></name><etal/></person-group>             <year>1998</year>             <article-title>Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum.</article-title>             <source>Proc Natl Acad Sci</source>             <volume>95</volume>             <fpage>12352</fpage>             <lpage>12357</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Waller2">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Waller</surname><given-names>R. F</given-names></name><name name-style="western"><surname>Reed</surname><given-names>M. B</given-names></name><name name-style="western"><surname>Cowman</surname><given-names>A. F</given-names></name><name name-style="western"><surname>McFadden</surname><given-names>G. I</given-names></name></person-group>             <year>2000</year>             <article-title>Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway.</article-title>             <source>EMBO J</source>             <volume>19</volume>             <fpage>1794</fpage>             <lpage>1802</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Dahl1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dahl</surname><given-names>E. L</given-names></name><name name-style="western"><surname>Shock</surname><given-names>J. L</given-names></name><name name-style="western"><surname>Shenai</surname><given-names>B. R</given-names></name><name name-style="western"><surname>Gut</surname><given-names>J</given-names></name><name name-style="western"><surname>DeRisi</surname><given-names>J. L</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum.</article-title>             <source>Antimicrobial Agents and Chemotherapy</source>             <volume>50</volume>             <fpage>3124</fpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Stanway1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Stanway</surname><given-names>R</given-names></name><name name-style="western"><surname>Witt</surname><given-names>T</given-names></name><name name-style="western"><surname>Zobiak</surname><given-names>B</given-names></name><name name-style="western"><surname>Aepfelbacher</surname><given-names>M</given-names></name><name name-style="western"><surname>Heussler</surname><given-names>V</given-names></name></person-group>             <year>2009</year>             <article-title>GFP-targeting allows visualization of the apicoplast throughout the life cycle of live malaria parasites.</article-title>             <source>Biology of the Cell</source>             <volume>101</volume>             <fpage>415</fpage>             <lpage>430</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Sullivan1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>M. J</given-names></name><name name-style="western"><surname>McCutchan</surname><given-names>T. F</given-names></name></person-group>             <year>2000</year>             <article-title>Effects of interruption of apicoplast function on malaria infection, development, and transmission.</article-title>             <source>Molecular and Biochemical Parasitology</source>             <volume>109</volume>             <fpage>17</fpage>             <lpage>23</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Okamoto1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Okamoto</surname><given-names>N</given-names></name><name name-style="western"><surname>Spurck</surname><given-names>T. P</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>C. D</given-names></name><name name-style="western"><surname>McFadden</surname><given-names>G. I</given-names></name></person-group>             <year>2009</year>             <article-title>Apicoplast and mitochondrion in gametocytogenesis of plasmodium falciparum.</article-title>             <source>Eukaryotic Cell</source>             <volume>8</volume>             <fpage>128</fpage>             <lpage>132</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Shimizu1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name><name name-style="western"><surname>Osada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kanazawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Arai</surname><given-names>M</given-names></name></person-group>             <year>2010</year>             <article-title>Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication.</article-title>             <source>Malaria Journal</source>             <volume>9</volume>             <fpage>73</fpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Aminake1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Aminake</surname><given-names>M. N</given-names></name><name name-style="western"><surname>Schoof</surname><given-names>S</given-names></name><name name-style="western"><surname>Sologub</surname><given-names>L</given-names></name><name name-style="western"><surname>Leubner</surname><given-names>M</given-names></name><name name-style="western"><surname>Kirschner</surname><given-names>M</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Thiostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast.</article-title>             <source>Antimicrob Agents Chemother</source>             <volume>55</volume>             <fpage>1338</fpage>             <lpage>1348</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Dahl2">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dahl</surname><given-names>E. L</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>P. J</given-names></name></person-group>             <year>2007</year>             <article-title>Multiple antibiotics exert delayed effects against the plasmodium falciparum apicoplast.</article-title>             <source>Antimicrob Agents Chemother</source>             <volume>51</volume>             <fpage>3485</fpage>             <lpage>3490</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Fichera1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Fichera</surname><given-names>M. E</given-names></name><name name-style="western"><surname>Roos</surname><given-names>D. S</given-names></name></person-group>             <year>1997</year>             <article-title>A plastid organelle as a drug target in apicomplexan parasites.</article-title>             <source>Nature</source>             <volume>390</volume>             <fpage>407</fpage>             <lpage>409</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-He1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>C. Y</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>M. K</given-names></name><name name-style="western"><surname>Pletcher</surname><given-names>C. H</given-names></name><name name-style="western"><surname>Striepen</surname><given-names>B</given-names></name><name name-style="western"><surname>Tilney</surname><given-names>L. G</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>A plastid segregation defect in the protozoan parasite Toxoplasma gondii.</article-title>             <source>EMBO J</source>             <volume>20</volume>             <fpage>330</fpage>             <lpage>339</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Zuegge1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zuegge</surname><given-names>J</given-names></name><name name-style="western"><surname>Ralph</surname><given-names>S</given-names></name><name name-style="western"><surname>Schmuker</surname><given-names>M</given-names></name><name name-style="western"><surname>McFadden</surname><given-names>G. I</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>G</given-names></name></person-group>             <year>2001</year>             <article-title>Deciphering apicoplast targeting signals–feature extraction from nuclear-encoded precursors of Plasmodium falciparum apicoplast proteins.</article-title>             <source>Gene</source>             <volume>280</volume>             <fpage>19</fpage>             <lpage>26</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Foth1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Foth</surname><given-names>B. J</given-names></name><name name-style="western"><surname>Ralph</surname><given-names>S. A</given-names></name><name name-style="western"><surname>Tonkin</surname><given-names>C. J</given-names></name><name name-style="western"><surname>Struck</surname><given-names>N. S</given-names></name><name name-style="western"><surname>Fraunholz</surname><given-names>M</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum.</article-title>             <source>Science</source>             <volume>299</volume>             <fpage>705</fpage>             <lpage>708</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Ralph1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ralph</surname><given-names>S. A</given-names></name><name name-style="western"><surname>van Dooren</surname><given-names>G. G</given-names></name><name name-style="western"><surname>Waller</surname><given-names>R. F</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>M. J</given-names></name><name name-style="western"><surname>Fraunholz</surname><given-names>M. J</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.</article-title>             <source>Nat Rev Microbiol</source>             <volume>2</volume>             <fpage>203</fpage>             <lpage>216</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Seeber1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Seeber</surname><given-names>F</given-names></name><name name-style="western"><surname>Soldati-Favre</surname><given-names>D</given-names></name></person-group>             <year>2010</year>             <article-title>Metabolic pathways in the apicoplast of apicomplexa.</article-title>             <source>Int Rev Cell Mol Biol</source>             <volume>281</volume>             <fpage>161</fpage>             <lpage>228</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Surolia1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Surolia</surname><given-names>N</given-names></name><name name-style="western"><surname>Surolia</surname><given-names>A</given-names></name></person-group>             <year>2001</year>             <article-title>Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.</article-title>             <source>Nature Medicine</source>             <volume>7</volume>             <fpage>167</fpage>             <lpage>173</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Yu1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>M</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>T. R</given-names></name><name name-style="western"><surname>Nkrumah</surname><given-names>L. J</given-names></name><name name-style="western"><surname>Coppi</surname><given-names>A</given-names></name><name name-style="western"><surname>Retzlaff</surname><given-names>S</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites.</article-title>             <source>Cell Host &amp; Microbe</source>             <volume>4</volume>             <fpage>567</fpage>             <lpage>578</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Vaughan1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vaughan</surname><given-names>A. M</given-names></name><name name-style="western"><surname>O'Neill</surname><given-names>M. T</given-names></name><name name-style="western"><surname>Tarun</surname><given-names>A. S</given-names></name><name name-style="western"><surname>Camargo</surname><given-names>N</given-names></name><name name-style="western"><surname>Phuong</surname><given-names>T. M</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.</article-title>             <source>Cellular Microbiology</source>             <volume>11</volume>             <fpage>506</fpage>             <lpage>520</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-He2">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>C. Y</given-names></name><name name-style="western"><surname>Striepen</surname><given-names>B</given-names></name><name name-style="western"><surname>Pletcher</surname><given-names>C. H</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J. M</given-names></name><name name-style="western"><surname>Roos</surname><given-names>D. S</given-names></name></person-group>             <year>2001</year>             <article-title>Targeting and processing of nuclear-encoded apicoplast proteins in plastid segregation mutants of Toxoplasma gondii.</article-title>             <source>J Biol Chem</source>             <volume>276</volume>             <fpage>28436</fpage>             <lpage>28442</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Kobayashi1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Sato</surname><given-names>S</given-names></name><name name-style="western"><surname>Takamiya</surname><given-names>S</given-names></name><name name-style="western"><surname>Komaki-Yasuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Yano</surname><given-names>K</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Mitochondria and apicoplast of Plasmodium falciparum: behaviour on subcellular fractionation and the implication.</article-title>             <source>Mitochondrion</source>             <volume>7</volume>             <fpage>125</fpage>             <lpage>132</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Moe1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Moe</surname><given-names>M. K</given-names></name><name name-style="western"><surname>Samuelsen</surname><given-names>P-J</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>H. V</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>K. M</given-names></name></person-group>             <year>2010</year>             <article-title>Separation of DNA-containing organelles from Toxoplasma gondii by CZE.</article-title>             <source>Electrophoresis</source>             <volume>31</volume>             <fpage>1344</fpage>             <lpage>1349</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Odom1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Odom</surname><given-names>A. R</given-names></name><name name-style="western"><surname>Van Voorhis</surname><given-names>W. C</given-names></name></person-group>             <year>2010</year>             <article-title>Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>170</volume>             <fpage>108</fpage>             <lpage>111</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Jomaa1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jomaa</surname><given-names>H</given-names></name><name name-style="western"><surname>Wiesner</surname><given-names>J</given-names></name><name name-style="western"><surname>Sanderbrand</surname><given-names>S</given-names></name><name name-style="western"><surname>Altincicek</surname><given-names>B</given-names></name><name name-style="western"><surname>Weidemeyer</surname><given-names>C</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.</article-title>             <source>Science</source>             <volume>285</volume>             <fpage>1573</fpage>             <lpage>1576</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Rohmer1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Rohmer</surname><given-names>M</given-names></name></person-group>             <year>1999</year>             <article-title>The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants.</article-title>             <source>Nat Prod Rep</source>             <volume>16</volume>             <fpage>565</fpage>             <lpage>574</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Wiesner1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wiesner</surname><given-names>J</given-names></name><name name-style="western"><surname>Borrmann</surname><given-names>S</given-names></name><name name-style="western"><surname>Jomaa</surname><given-names>H</given-names></name></person-group>             <year>2003</year>             <article-title>Fosmidomycin for the treatment of malaria.</article-title>             <source>Parasitology Research</source>             <volume>90</volume>             <fpage>71</fpage>             <lpage>76</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Oyakhirome1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Oyakhirome</surname><given-names>S</given-names></name><name name-style="western"><surname>Issifou</surname><given-names>S</given-names></name><name name-style="western"><surname>Pongratz</surname><given-names>P</given-names></name><name name-style="western"><surname>Barondi</surname><given-names>F</given-names></name><name name-style="western"><surname>Ramharter</surname><given-names>M</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.</article-title>             <source>Antimicrob Agents Chemother</source>             <volume>51</volume>             <fpage>1869</fpage>             <lpage>1871</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Dharia1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dharia</surname><given-names>N. V</given-names></name><name name-style="western"><surname>Sidhu</surname><given-names>A. B. S</given-names></name><name name-style="western"><surname>Cassera</surname><given-names>M. B</given-names></name><name name-style="western"><surname>Westenberger</surname><given-names>S. J</given-names></name><name name-style="western"><surname>Bopp</surname><given-names>S. E</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum.</article-title>             <source>Genome Biol</source>             <volume>10</volume>             <fpage>R21</fpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Dewick1">
        <label>34</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dewick</surname><given-names>P. M</given-names></name></person-group>             <year>2009</year>             <source>Medicinal natural products: a biosynthetic approach</source>             <publisher-name>John Wiley &amp; Sons Inc</publisher-name>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Nguyen1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>U. T. T</given-names></name><name name-style="western"><surname>Goody</surname><given-names>R. S</given-names></name><name name-style="western"><surname>Alexandrov</surname><given-names>K</given-names></name></person-group>             <year>2010</year>             <article-title>Understanding and exploiting protein prenyltransferases.</article-title>             <source>Chembiochem</source>             <volume>11</volume>             <fpage>1194</fpage>             <lpage>1201</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Painter1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Painter</surname><given-names>H. J</given-names></name><name name-style="western"><surname>Morrisey</surname><given-names>J. M</given-names></name><name name-style="western"><surname>Mather</surname><given-names>M. W</given-names></name><name name-style="western"><surname>Vaidya</surname><given-names>A. B</given-names></name></person-group>             <year>2007</year>             <article-title>Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum.</article-title>             <source>Nature</source>             <volume>446</volume>             <fpage>88</fpage>             <lpage>91</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Couto1">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Couto</surname><given-names>A. S</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>E. A</given-names></name><name name-style="western"><surname>Peres</surname><given-names>V. J</given-names></name><name name-style="western"><surname>Uhrig</surname><given-names>M. L</given-names></name><name name-style="western"><surname>Katzin</surname><given-names>A. M</given-names></name></person-group>             <year>1999</year>             <article-title>Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units.</article-title>             <source>Biochem J</source>             <volume>341</volume>             <issue>Pt. 3</issue>             <fpage>629</fpage>             <lpage>637</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Cassera1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cassera</surname><given-names>M. B</given-names></name><name name-style="western"><surname>Gozzo</surname><given-names>F. C</given-names></name><name name-style="western"><surname>D'Alexandri</surname><given-names>F. L</given-names></name><name name-style="western"><surname>Merino</surname><given-names>E. F</given-names></name><name name-style="western"><surname>del Portillo</surname><given-names>H. A</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.</article-title>             <source>J Biol Chem</source>             <volume>279</volume>             <fpage>51749</fpage>             <lpage>51759</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Chakrabarti1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chakrabarti</surname><given-names>D</given-names></name><name name-style="western"><surname>Azam</surname><given-names>T</given-names></name><name name-style="western"><surname>DelVecchio</surname><given-names>C</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>L</given-names></name><name name-style="western"><surname>Park</surname><given-names>Y. I</given-names></name><etal/></person-group>             <year>1998</year>             <article-title>Protein prenyl transferase activities of Plasmodium falciparum.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>94</volume>             <fpage>175</fpage>             <lpage>184</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Quevillon1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Quevillon</surname><given-names>E</given-names></name><name name-style="western"><surname>Spielmann</surname><given-names>T</given-names></name><name name-style="western"><surname>Brahimi</surname><given-names>K</given-names></name><name name-style="western"><surname>Chattopadhyay</surname><given-names>D</given-names></name><name name-style="western"><surname>Yeramian</surname><given-names>E</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>The Plasmodium falciparum family of Rab GTPases.</article-title>             <source>Gene</source>             <volume>306</volume>             <fpage>13</fpage>             <lpage>25</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Pendyala1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pendyala</surname><given-names>P. R</given-names></name><name name-style="western"><surname>Ayong</surname><given-names>L</given-names></name><name name-style="western"><surname>Eatrides</surname><given-names>J</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>M</given-names></name><name name-style="western"><surname>Pham</surname><given-names>C</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Characterization of a PRL protein tyrosine phosphatase from Plasmodium falciparum.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>158</volume>             <fpage>1</fpage>             <lpage>10</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Pei1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tarun</surname><given-names>A. S</given-names></name><name name-style="western"><surname>Vaughan</surname><given-names>A. M</given-names></name><name name-style="western"><surname>Herman</surname><given-names>R. W</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>J. M. B</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection.</article-title>             <source>Mol Microbiol</source>             <volume>75</volume>             <fpage>957</fpage>             <lpage>971</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Bonday1">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bonday</surname><given-names>Z. Q</given-names></name><name name-style="western"><surname>Taketani</surname><given-names>S</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>P. D</given-names></name><name name-style="western"><surname>Padmanaban</surname><given-names>G</given-names></name></person-group>             <year>1997</year>             <article-title>Heme biosynthesis by the malarial parasite. Import of delta-aminolevulinate dehydrase from the host red cell.</article-title>             <source>J Biol Chem</source>             <volume>272</volume>             <fpage>21839</fpage>             <lpage>21846</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Dhanasekaran1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dhanasekaran</surname><given-names>S</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>N. R</given-names></name><name name-style="western"><surname>Chandrasekhar Sagar</surname><given-names>B. K</given-names></name><name name-style="western"><surname>Rangarajan</surname><given-names>P. N</given-names></name><name name-style="western"><surname>Padmanaban</surname><given-names>G</given-names></name></person-group>             <year>2004</year>             <article-title>Delta-aminolevulinic acid dehydratase from Plasmodium falciparum: indigenous versus imported.</article-title>             <source>J Biol Chem</source>             <volume>279</volume>             <fpage>6934</fpage>             <lpage>6942</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Sherman1">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sherman</surname><given-names>I. W</given-names></name></person-group>             <year>1977</year>             <article-title>Amino acid metabolism and protein synthesis in malarial parasites.</article-title>             <source>Bull World Health Organ</source>             <volume>55</volume>             <fpage>265</fpage>             <lpage>276</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Kirk1">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kirk</surname><given-names>K</given-names></name></person-group>             <year>2001</year>             <article-title>Membrane transport in the malaria-infected erythrocyte.</article-title>             <source>Physiol Rev</source>             <volume>81</volume>             <fpage>495</fpage>             <lpage>537</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Liu1">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Istvan</surname><given-names>E. S</given-names></name><name name-style="western"><surname>Gluzman</surname><given-names>I. Y</given-names></name><name name-style="western"><surname>Gross</surname><given-names>J</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>D. E</given-names></name></person-group>             <year>2006</year>             <article-title>Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>103</volume>             <fpage>8840</fpage>             <lpage>8845</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Divo1">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Divo</surname><given-names>A. A</given-names></name><name name-style="western"><surname>Geary</surname><given-names>T. G</given-names></name><name name-style="western"><surname>Davis</surname><given-names>N. L</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>J. B</given-names></name></person-group>             <year>1985</year>             <article-title>Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth.</article-title>             <source>J Protozool</source>             <volume>32</volume>             <fpage>59</fpage>             <lpage>64</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Geary1">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Geary</surname><given-names>T. G</given-names></name><name name-style="western"><surname>Divo</surname><given-names>A. A</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>J. B</given-names></name></person-group>             <year>1985</year>             <article-title>Nutritional requirements of Plasmodium falciparum in culture. II. Effects of antimetabolites in a semi-defined medium.</article-title>             <source>J Protozool</source>             <volume>32</volume>             <fpage>65</fpage>             <lpage>69</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Mller1">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Müller</surname><given-names>S</given-names></name><name name-style="western"><surname>Kappes</surname><given-names>B</given-names></name></person-group>             <year>2007</year>             <article-title>Vitamin and cofactor biosynthesis pathways in Plasmodium and other apicomplexan parasites.</article-title>             <source>Trends Parasitol</source>             <volume>23</volume>             <fpage>112</fpage>             <lpage>121</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Ginsburg1">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ginsburg</surname><given-names>H</given-names></name><name name-style="western"><surname>Kutner</surname><given-names>S</given-names></name><name name-style="western"><surname>Krugliak</surname><given-names>M</given-names></name><name name-style="western"><surname>Cabantchik</surname><given-names>Z. I</given-names></name></person-group>             <year>1985</year>             <article-title>Characterization of permeation pathways appearing in the host membrane of Plasmodium falciparum infected red blood cells.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>14</volume>             <fpage>313</fpage>             <lpage>322</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Wiback1">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wiback</surname><given-names>S. J</given-names></name><name name-style="western"><surname>Palsson</surname><given-names>B. O</given-names></name></person-group>             <year>2002</year>             <article-title>Extreme pathway analysis of human red blood cell metabolism.</article-title>             <source>Biophys J</source>             <volume>83</volume>             <fpage>808</fpage>             <lpage>818</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Psychogios1">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Psychogios</surname><given-names>N</given-names></name><name name-style="western"><surname>Hau</surname><given-names>D. D</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>A. C</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>R</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>The human serum metabolome.</article-title>             <source>PLoS ONE</source>             <volume>6</volume>             <fpage>e16957</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0016957" xlink:type="simple">10.1371/journal.pone.0016957</ext-link></comment>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Brooks1">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>C. F</given-names></name><name name-style="western"><surname>Johnsen</surname><given-names>H</given-names></name><name name-style="western"><surname>van Dooren</surname><given-names>G. G</given-names></name><name name-style="western"><surname>Muthalagi</surname><given-names>M</given-names></name><name name-style="western"><surname>Lin</surname><given-names>S. S</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>The toxoplasma apicoplast phosphate translocator links cytosolic and apicoplast metabolism and is essential for parasite survival.</article-title>             <source>Cell Host &amp; Microbe</source>             <volume>7</volume>             <fpage>62</fpage>             <lpage>73</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Mohanty1">
        <label>55</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mohanty</surname><given-names>S</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>N</given-names></name></person-group>             <year>2009</year>             <article-title>Identification of “missing” metabolic proteins of Plasmodium falciparum: a bioinformatics approach.</article-title>             <source>Protein Pept Lett</source>             <volume>16</volume>             <fpage>961</fpage>             <lpage>968</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Zhang1">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Watts</surname><given-names>K. M</given-names></name><name name-style="western"><surname>Hodge</surname><given-names>D</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>L. M</given-names></name><name name-style="western"><surname>Hunstad</surname><given-names>D. A</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.</article-title>             <source>Biochemistry</source>             <volume>50</volume>             <fpage>3570</fpage>             <lpage>3577</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-McCarthy1">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>McCarthy</surname><given-names>J. S</given-names></name><name name-style="western"><surname>Good</surname><given-names>M. F</given-names></name></person-group>             <year>2010</year>             <article-title>Whole parasite blood stage malaria vaccines: a convergence of evidence.</article-title>             <source>Hum Vaccin</source>             <volume>6</volume>             <fpage>114</fpage>             <lpage>123</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Good1">
        <label>58</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Good</surname><given-names>M. F</given-names></name></person-group>             <year>2011</year>             <article-title>A whole parasite vaccine to control the blood stages of Plasmodium - the case for lateral thinking.</article-title>             <source>Trends Parasitol</source>             <comment>In press</comment>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Friesen1">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Friesen</surname><given-names>J</given-names></name><name name-style="western"><surname>Silvie</surname><given-names>O</given-names></name><name name-style="western"><surname>Putrianti</surname><given-names>E. D</given-names></name><name name-style="western"><surname>Hafalla</surname><given-names>J. C. R</given-names></name><name name-style="western"><surname>Matuschewski</surname><given-names>K</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Natural immunization against malaria: causal prophylaxis with antibiotics.</article-title>             <source>Science Translational Medicine</source>             <volume>2</volume>             <fpage>40</fpage>             <lpage>49</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Vaughan2">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vaughan</surname><given-names>A. M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Kappe</surname><given-names>S. H. I</given-names></name></person-group>             <year>2010</year>             <article-title>Genetically engineered, attenuated whole-cell vaccine approaches for malaria.</article-title>             <source>Hum Vaccin</source>             <volume>6</volume>             <fpage>107</fpage>             <lpage>113</lpage>          </element-citation>
      </ref>
      <ref id="pbio.1001138-Pfaffl1">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pfaffl</surname><given-names>M. W</given-names></name></person-group>             <year>2001</year>             <article-title>A new mathematical model for relative quantification in real-time RT-PCR.</article-title>             <source>Nucleic Acids Res</source>             <volume>29</volume>             <fpage>e45</fpage>          </element-citation>
      </ref>
    </ref-list>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>DMAPP</term>
          <def>
            <p>dimethylallyl pyrophosphate</p>
          </def>
        </def-item>
        <def-item>
          <term>GFP</term>
          <def>
            <p>green fluorescent protein</p>
          </def>
        </def-item>
        <def-item>
          <term>IPP</term>
          <def>
            <p>isopentenyl pyrophosphate</p>
          </def>
        </def-item>
        <def-item>
          <term>RBC</term>
          <def>
            <p>red blood cell</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    
  </back>
</article>